A detailed history of Bailard, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Bailard, Inc. holds 750 shares of MEDP stock, worth $250,012. This represents 0.01% of its overall portfolio holdings.

Number of Shares
750
Previous 750 -0.0%
Holding current value
$250,012
Previous $303,000 1.65%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$227.52 - $312.68 $91,008 - $125,072
-400 Reduced 34.78%
750 $229,000
Q1 2023

May 08, 2023

BUY
$174.31 - $239.52 $200,456 - $275,448
1,150 New
1,150 $216,000
Q1 2019

Apr 24, 2019

SELL
$49.38 - $70.58 $404,916 - $578,756
-8,200 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$46.97 - $63.98 $164,395 - $223,930
-3,500 Reduced 29.91%
8,200 $434,000
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $506,025 - $745,758
11,700 New
11,700 $701,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.